Wang Juan, Hao Lin, Wang Yan, Qin Weidong, Wang Xin, Zhao Tong, Liu Yusheng, Sheng Lin, Du Yimeng, Zhang Mengyuan, Lu Qinghua
Department of Cardiovascular Medicine, The Second Hospital of Shandong University, Jinan, Shandong 250033, P.R. China.
Department of Anesthesiology, Provincial Hospital Affiliated to Shandong University, Jinan, Shandong 250062, P.R. China.
Mol Med Rep. 2015 Mar;11(3):1768-76. doi: 10.3892/mmr.2014.2977. Epub 2014 Nov 19.
Myocardial infarction (MI) is defined as the deprivation of the myocardial tissue of oxygen and nutrients, resulting in the induction of inflammation and apoptosis of the cardiomyocytes. Poly (ADP‑ribose) polymerase 1 (PARP1) is a nuclear enzyme closely associated with MI, that can be activated by DNA damage. Inducible nitric oxide synthase (iNOS) is a critical enzyme among the inflammatory cytokines. The present study aimed to investigate the underlying mechanism of the protective effects of PARP1 and iNOS inhibitor against MI, in rats. A total of 40 male Wistar rats were divided into four groups. The rats were anesthetized with sodium pentobarbital (50 mg/kg), and the left anterior descending coronary artery was occluded by ligation, using a 6‑0 polypropylene monofilament suture, at the left atrial apex, in order to induce MI. The rats from each group received an abdominal injection of either dimethylsulfoxide (100 µl, for MI group); PARP‑1 inhibitor, 3,4‑dihydro‑5‑[4‑(1‑piperidinyl)butoxy]‑1(2H)‑ isoquinolinone (DPQ; 10 mg/kg); or iNOS inhibitor, N‑(1‑naphthyl)ethylenediamine dihydrochloride (1400W; 10 mg/kg). The hearts were harvested from the rats after four weeks. Inhibition of PARP and iNOS activity improved heart function, as determined by serial echocardiography. The rate of apoptosis, as determined by a terminal deoxynucleotidyl‑transferase‑mediated dUTP nick end labeling assay, was reduced by 39.71 and 39.00% in the DPQ and 1400W groups, respectively, and this was accompanied by the downregulated expression of cleaved caspase‑3 and PARP1. Effective inhibition of PARP and iNOS, by DPQ and 1400W, was detected by western blotting and immunofluorescence, and was shown to repress O2‑ and nitrotyrosine levels, following MI. The present study confirmed that inhibition of PARP1 and iNOS was able to protect against ischemic myocardial damage, by reducing the levels of apoptosis.
心肌梗死(MI)被定义为心肌组织氧和营养物质的缺失,导致心肌细胞炎症和凋亡的诱导。聚(ADP - 核糖)聚合酶1(PARP1)是一种与心肌梗死密切相关的核酶,可被DNA损伤激活。诱导型一氧化氮合酶(iNOS)是炎性细胞因子中的关键酶。本研究旨在探讨PARP1和iNOS抑制剂对大鼠心肌梗死保护作用的潜在机制。总共40只雄性Wistar大鼠被分为四组。大鼠用戊巴比妥钠(50 mg/kg)麻醉,在左心耳尖部用6 - 0聚丙烯单丝缝线结扎左冠状动脉前降支以诱导心肌梗死。每组大鼠腹腔注射二甲基亚砜(100 μl,MI组);PARP - 1抑制剂3,4 - 二氢 - 5 - [4 - (1 - 哌啶基)丁氧基] - 1(2H) - 异喹啉酮(DPQ;10 mg/kg);或iNOS抑制剂N - (1 - 萘基)乙二胺二盐酸盐(1400W;10 mg/kg)。四周后从大鼠体内取出心脏。连续超声心动图测定结果显示,抑制PARP和iNOS活性可改善心脏功能。通过末端脱氧核苷酸转移酶介导的dUTP缺口末端标记法测定,DPQ组和1400W组的凋亡率分别降低了39.71%和39.00%,同时伴有裂解的半胱天冬酶 - 3和PARP1表达下调。通过蛋白质印迹法和免疫荧光检测发现,DPQ和1400W有效抑制了PARP和iNOS,并显示在心肌梗死后可降低超氧阴离子和硝基酪氨酸水平。本研究证实,抑制PARP1和iNOS能够通过降低凋亡水平来预防缺血性心肌损伤。